BN Business News
添加企业 →
本文翻译正在准备中。在此之前,我们暂时显示英文原文。

市场监管 · 1996/4/171 分钟阅读

Arizona Institute of Reproductive Medicine, Ltd.; Prohibited Trade Practices, and Affirmative Corrective Actions

本地自动翻译 · 来源原始语言

摘要

In settlement of alleged violations of federal law prohibiting unfair or deceptive acts or practices and unfair methods of competition, this consent order prohibits, among other things, an Arizona institute and its president from misrepresenting the success rate of their in vitro fertilization program or any other infertility treatment services. In addition, the consent order stipulates that any comparison with other success rates be based upon the same calculating methodology. Finally, the order requires the respondents to possess competent and reliable scientific evidence for any future comparative success-rate claims for fertility services.

来源原始语言: Federal Register — Federal Trade Commission打开原始公告 →

探索专题

商业洞察 →